Parkinson’s Disease Clinical Trial Solutions from Cogstate

While motor function is a hallmark of Parkinson’s disease (PD) clinical trials, drug development efforts are increasingly addressing additional aspects of the disease including cognitive impairment, as patients note these symptoms as being among the most impactful aspects of living with PD.

Cogstate helps sponsors gather high quality data in PD trials by providing sensitive and reliable computerized cognitive testing, as well as supporting rater training, central monitoring, and eCOA for the full range of clinical outcome assessments including motor function, quality of life, cognition, depression, suicidality, symptom severity, and sleep.

Download the fact sheet below to learn more about we support PD clinical trials globally.

Download Fact Sheet

Back to Fact Sheets